RESISTENTIA PHARMACEUTICALS AB has a total of 34 patent applications. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are HOVENS CHRISTOPHER, POLYPHOR LTD and ZEALAND PHARMACEUTICALS AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Australia | 5 | |
#3 | United States | 5 | |
#4 | Canada | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Norway | 2 | |
#7 | New Zealand | 2 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Mexico | 1 | |
#14 | Poland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hellman Lars T | 23 |
#2 | Holmdahl Rikard | 8 |
#3 | Lundgren Mats | 5 |
#4 | Magnusson Ann-Christin | 5 |
#5 | Fuentes Alexis | 5 |
#6 | Persson Stephen | 4 |
#7 | Gansson Asa | 2 |
#8 | Jansson Asa | 2 |
#9 | Persson Stefan | 1 |
#10 | Rikard Holmdahl | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008046615A2 | Anti-ige vaccines | |
KR20050090390A | Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment | |
CA2497660A1 | Allergy vaccines | |
US7232898B2 | Chimeric IgE polypeptides and host cells | |
EP1621209A2 | Vaccines based on domains of chimeric immunoglobulin E peptides | |
US6913749B2 | Immunogenic polypeptides for inducing anti-self IgE responses | |
EP0666760A1 | VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |